Welcome to the tag category page for Pyridoxine!
Cefpodoxime proxetil is an oral third‑generation cephalosporin antibiotic used to treat a range of bacterial infections, including otitis media, pharyngitis, sinusitis, bronchitis, urinary tract infections, skin infections, and some sexually transmitted infections. It is a prodrug that is absorbed from the gut and de‑esterified to the active agent, cefpodoxime, which exerts bactericidal activity by inhibiting cell wall synthesis. Clinically it is valued as a broad‑spectrum outpatient option, often used in pediatric and adult respiratory and ENT infections; some studies have shown comparable or superior effectiveness to agents such as amoxicillin/clavulanate in selected settings. Common adverse effects include gastrointestinal upset, diarrhea, and hypersensitivity reactions; caution is advised in patients with a history of beta‑lactam allergy. From a market perspective, cefpodoxime is widely available as a generic, supporting cost‑sensitive prescribing, while antimicrobial stewardship and evolving resistance patterns continue to shape its use and guideline recommendations.
